Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

MYGN

MYRIAD GENETICS INC

CIK 0000899923 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$3.20
↓ 0.02 (-0.62%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals, Technicals

Key stats

Market Cap
$306.08M
P/E Ratio
-2.72
EPS
-3.95
Dividend Yield
Not covered
52W Position
8%
Beta
1.11

Valuation multiples

Fwd P/E
54.05
PEG
1.40
P/B
1.01
P/S
0.38
EV/Revenue
0.39
ROE
-37.1%
Valuation data covers 8,723/9,697 US-listed stocks (90.0%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 8%
$2.74$8.59

Latest Financials

2025-12-31 FY
Revenue
$824.50M
Net Income
-$365.90M
Total Assets
$706.60M
Free Cash Flow
–

Recent news